Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Head and Neck Cancer Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Yale Cancer Center, New Haven, Connecticut, United States
Contact: Study coordinator (Clinical Research Coordinator) · anna.wu@yale.edu · 203-228-2385
NYU Langone Health, Manhattan, New York, United States
CRM · ynmoon@vspharmtech.com · +82 1099171335

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PDT For Induction Therapy For Head And Neck Cancer

Squamous Cell Carcinoma · Head and Neck Cancer Squamous Cell Carcinoma · Head and Neck Cancer

Abroad (travel likely)RecruitingPHASE2

Boston, United States · Boston, United States

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States

Response Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC

Head and Neck Cancer

Abroad (travel likely)RecruitingPHASE2

Beijing, China

Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery

Head and Neck Cancer · Head and Neck Squamous Cell Carcinoma HNSCC

Abroad (travel likely)Recruiting

Charlotte, United States · Winston-Salem, United States